CN100362991C - 一种眼科用药物组合物 - Google Patents
一种眼科用药物组合物 Download PDFInfo
- Publication number
- CN100362991C CN100362991C CNB200410046029XA CN200410046029A CN100362991C CN 100362991 C CN100362991 C CN 100362991C CN B200410046029X A CNB200410046029X A CN B200410046029XA CN 200410046029 A CN200410046029 A CN 200410046029A CN 100362991 C CN100362991 C CN 100362991C
- Authority
- CN
- China
- Prior art keywords
- sodium
- composition
- trometamol
- diclofenac sodium
- thimerosal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
Description
眼刺激反应 | 分值 |
角膜混浊(以最致密部位为准)无混浊散在或弥漫性混浊,虹膜清晰可见半透明区易分辨,虹膜模糊不清出现灰白色透明区,虹膜细节不清,瞳孔大小勉强看清角膜不透明,由于混浊,虹膜无法辨认 | 01234 |
虹膜正常皱褶明显加深,充血、肿胀、角膜周围有轻度充血,瞳孔对光仍有反应出血,肉眼可见坏死、对光无反应(或出现其中一种反应 | 012 |
结膜充血(指睑结膜、球结膜部位)血管正常血管充血呈红色血管充血呈红色,血管不易分辨弥漫性充血呈紫红色 | 0123 |
水肿无水肿轻微水肿(包括膦膜)明显水肿,伴有部分睑外翻水肿至眼睑近半闭合水肿至眼睑超过半闭合 | 01234 |
分泌物无分泌物少量分泌物分泌物使眼睑和睫毛潮湿或粘着分泌物使整个眼区潮湿或粘着 | 0123 |
总积分 | 16 |
眼刺激性评价标准无刺激性轻度刺激性中度刺激性强度刺激性 | 积分0-34-89-1213-16 |
组别 | 动物数 | 刺激得分 |
ABCD | 4444 | 2.652.5011.509.75 |
组别 | 动物数 | 刺激得分 |
ABCD | 8888 | 3.753.0014.259.50 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200410046029XA CN100362991C (zh) | 2004-06-02 | 2004-06-02 | 一种眼科用药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200410046029XA CN100362991C (zh) | 2004-06-02 | 2004-06-02 | 一种眼科用药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1704067A CN1704067A (zh) | 2005-12-07 |
CN100362991C true CN100362991C (zh) | 2008-01-23 |
Family
ID=35575790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200410046029XA Active CN100362991C (zh) | 2004-06-02 | 2004-06-02 | 一种眼科用药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100362991C (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI465236B (zh) * | 2007-03-13 | 2014-12-21 | 參天製藥股份有限公司 | 含有吡諾克辛之懸浮型水性液劑 |
CN102942546A (zh) * | 2012-12-04 | 2013-02-27 | 广东中科药物研究有限公司 | 一种用于制备滴眼液的新化合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1071575A (zh) * | 1991-10-22 | 1993-05-05 | 沈阳市兴齐制药厂 | 复方醋酸去炎松涂膜剂的制备方法 |
CN1296815A (zh) * | 1999-11-23 | 2001-05-30 | 刘继东 | 双氯酚酸钠滴眼液 |
CN1488404A (zh) * | 2003-06-19 | 2004-04-14 | 刘继东 | 眼用制剂中玻璃酸钠的复合应用 |
-
2004
- 2004-06-02 CN CNB200410046029XA patent/CN100362991C/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1071575A (zh) * | 1991-10-22 | 1993-05-05 | 沈阳市兴齐制药厂 | 复方醋酸去炎松涂膜剂的制备方法 |
CN1296815A (zh) * | 1999-11-23 | 2001-05-30 | 刘继东 | 双氯酚酸钠滴眼液 |
CN1488404A (zh) * | 2003-06-19 | 2004-04-14 | 刘继东 | 眼用制剂中玻璃酸钠的复合应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1704067A (zh) | 2005-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111991415B (zh) | 一种眼部护理组合物及其制备方法和用途 | |
CN107456440A (zh) | 一种低浓度阿托品类药物滴眼液及其制备方法 | |
CN104546670A (zh) | 前列腺素F2α及类似物用于愈合角膜和结膜损害的用途 | |
Vale et al. | Drugs and the Eye: Sponsored by the British Optical Association | |
CN101543509B (zh) | 含有硫酸软骨素的眼用凝胶剂及其制备方法 | |
CN100362991C (zh) | 一种眼科用药物组合物 | |
CN112891326B (zh) | 一种载有那他霉素的海藻酸凝胶药膜及其制备方法 | |
CN109453151B (zh) | 眼用药物组合物、其制备方法及其应用 | |
CN104606666A (zh) | 重组牛碱性成纤维细胞生长因子滴眼液 | |
EP3682867B1 (en) | Lutein-containing ophthalmic composition | |
CN106692048A (zh) | 一种含有聚乙烯醇的单剂量滴眼液及其制备方法 | |
CN108066282B (zh) | 一种左氧氟沙星滴眼液及其制备方法 | |
CN102579492A (zh) | 一种含小牛血去蛋白提取物的玻璃酸钠滴眼液及其制备方法 | |
CN102008488A (zh) | 一种曲安奈德眼用制剂及其制备方法 | |
CN107802597B (zh) | 一种玻璃酸钠组合物及其制备方法和应用 | |
CN105168237A (zh) | 一种复方凝胶保湿润眼液 | |
CN109200016A (zh) | 一种苄达赖氨酸滴眼液及其制备方法与用途 | |
JP2002527382A (ja) | ヒストクロームおよびその眼科治療における使用 | |
CN102018656A (zh) | 含有效成分拉坦前列素的眼用凝胶剂及其制备方法 | |
CN1459291A (zh) | 含低分子肝素的滴眼液及其制备方法 | |
KR101134340B1 (ko) | 안과질환 예방 또는 치료용 점안제 조성물 | |
US11779593B2 (en) | Agent for improving ocular subjective symptoms and method thereof | |
CN110200904B (zh) | 一种降眼压缓释滴眼组合物及其制备方法 | |
CN102512362B (zh) | 一种复方环丙沙星滴眼液的配方及制备方法 | |
RU2460502C1 (ru) | Способ лечения возрастной начинающейся катаракты |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: SHENYANG SINQI PHARMACEUTICAL Co.,Ltd. Assignor: Liu Jidong Contract fulfillment period: 2008.9.22 to 2008.9.22 Contract record no.: 2008210000057 Denomination of invention: Medicine composition for ophthalmology department Granted publication date: 20080123 License type: Exclusive license Record date: 20081106 Assignee: SHENYANG SINQI PHARMACEUTICAL Co.,Ltd. Assignor: Liu Jidong Contract fulfillment period: 2008.9.29 to 2013.9.29 Contract record no.: 2008210000056 Denomination of invention: Medicine composition for ophthalmology department Granted publication date: 20080123 License type: Exclusive license Record date: 20081105 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.9.29 TO 2013.9.29; CHANGE OF CONTRACT Name of requester: SHENYANG XING QI PHARMACEUTICAL CO., LTD. Effective date: 20081105 Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.9.22 TO 2008.9.22; CHANGE OF CONTRACT Name of requester: SHENYANG XING QI PHARMACEUTICAL CO., LTD. Effective date: 20081106 |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: SHENYANG SINQI PHARMACEUTICAL Co.,Ltd. Assignor: Liu Jidong Contract fulfillment period: 2008.9.29 to 2013.9.29 Contract record no.: 2008210000056 Denomination of invention: Medicine composition for ophthalmology department Granted publication date: 20080123 License type: Exclusive license Record date: 20081105 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.9.29 TO 2013.9.29; CHANGE OF CONTRACT Name of requester: SHENYANG XING QI PHARMACEUTICAL CO., LTD. Effective date: 20081105 |
|
ASS | Succession or assignment of patent right |
Owner name: SHENYANG XINGQI MEDICINE CO., LTD. Free format text: FORMER OWNER: LIU JIDONG Effective date: 20111013 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20111013 Address after: 110027 No. 12, 4, three street, Shenyang economic and Technological Development Zone, Liaoning, China Patentee after: SHENYANG SINQI PHARMACEUTICAL Co.,Ltd. Address before: 110027 No. 12, 4, three street, Shenyang economic and Technological Development Zone, Liaoning, China Patentee before: Liu Jidong |
|
C56 | Change in the name or address of the patentee |
Owner name: SHENYANG SINQI EYE PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: SHENYANG XINGQI MEDICINE CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 110024 No. 12, 4, three street, Shenyang economic and Technological Development Zone, Liaoning, China Patentee after: SHENYANG XINGQI PHARMACEUTICAL Co.,Ltd. Address before: 110027 No. 12, 4, three street, Shenyang economic and Technological Development Zone, Liaoning, China Patentee before: SHENYANG SINQI PHARMACEUTICAL Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |
Address after: No. 25 Xinyunhe Road, Shenyang Area, China (Liaoning) Pilot Free Trade Zone, Shenyang City, Liaoning Province, 110000 Patentee after: SHENYANG XINGQI PHARMACEUTICAL Co.,Ltd. Address before: 110024 no.12a4, No.3 street, Shenyang Economic and Technological Development Zone, Liaoning Province Patentee before: SHENYANG XINGQI PHARMACEUTICAL Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |